164 related articles for article (PubMed ID: 1482702)
1. Correction of purine nucleoside phosphorylase deficiency by retroviral-mediated gene transfer in mouse S49 T cell lymphoma: a model for gene therapy of T cell immunodeficiency.
Foresman MD; Nelson DM; McIvor RS
Hum Gene Ther; 1992 Dec; 3(6):625-31. PubMed ID: 1482702
[TBL] [Abstract][Full Text] [Related]
2. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.
Nelson DM; Butters KA; Markert ML; Reinsmoen NL; McIvor RS
J Immunol; 1995 Mar; 154(6):3006-14. PubMed ID: 7876563
[TBL] [Abstract][Full Text] [Related]
3. TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice.
Toro A; Grunebaum E
J Clin Invest; 2006 Oct; 116(10):2717-26. PubMed ID: 16964310
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus gene therapy for purine nucleoside phosphorylase deficiency.
Liao P; Toro A; Min W; Lee S; Roifman CM; Grunebaum E
J Gene Med; 2008 Dec; 10(12):1282-93. PubMed ID: 18924118
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.
Ullman B; Gudas LJ; Clift SM; Martin DW
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1074-8. PubMed ID: 108675
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro.
Toro A; Paiva M; Ackerley C; Grunebaum E
Cell Immunol; 2006 Apr; 240(2):107-15. PubMed ID: 16930574
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.
Duan DS; Nagashima T; Hoshino T; Waldman F; Pawlak K; Sadee W
Biochem J; 1990 Jun; 268(3):725-31. PubMed ID: 2114100
[TBL] [Abstract][Full Text] [Related]
8. Retroviral-mediated gene transfer into mammalian cells.
Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
[TBL] [Abstract][Full Text] [Related]
9. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
North ME; Newton CA; Webster AD
Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
[TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).
Braun SE; Pan D; Aronovich EL; Jonsson JJ; McIvor RS; Whitley CB
Hum Gene Ther; 1996 Feb; 7(3):283-90. PubMed ID: 8835216
[TBL] [Abstract][Full Text] [Related]
13. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
[TBL] [Abstract][Full Text] [Related]
14. Purine nucleoside phosphorylase deficiency.
Markert ML
Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
[TBL] [Abstract][Full Text] [Related]
15. Retrovirus-mediated transduction of an engineered intron-containing purine nucleoside phosphorylase gene.
Jonsson JJ; Habel DE; McIvor RS
Hum Gene Ther; 1995 May; 6(5):611-23. PubMed ID: 7578398
[TBL] [Abstract][Full Text] [Related]
16. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene.
Hong JS; Waud WR; Levasseur DN; Townes TM; Wen H; McPherson SA; Moore BA; Bebok Z; Allan PW; Secrist JA; Parker WB; Sorscher EJ
Cancer Res; 2004 Sep; 64(18):6610-5. PubMed ID: 15374975
[TBL] [Abstract][Full Text] [Related]
17. Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans.
Osborne WR; Miller AD
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6851-5. PubMed ID: 3137573
[TBL] [Abstract][Full Text] [Related]
18. Purine nucleoside phosphorylase inhibitors in T-cell malignancies.
Bantia S; Kilpatrick JM
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):243-7. PubMed ID: 15603259
[TBL] [Abstract][Full Text] [Related]
19. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
Martiniello-Wilks R; Wang XY; Voeks DJ; Dane A; Shaw JM; Mortensen E; Both GW; Russell PJ
J Gene Med; 2004 Dec; 6(12):1343-57. PubMed ID: 15493036
[TBL] [Abstract][Full Text] [Related]
20. [Purine nucleoside phosphorylase (PNP)].
Taniguchi A
Nihon Rinsho; 2003 Jan; 61 Suppl 1():85-90. PubMed ID: 12629696
[No Abstract] [Full Text] [Related]
[Next] [New Search]